Summary of #394 ‒ Sleep pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements

Overview of #394 – Sleep Pharmacology: the role of medications in healthy sleep, the promise of emerging therapies, and the evidence for common sleep supplements

Peter Attia gives a detailed, clinically oriented tour of sleep pharmacology, emphasizing that sleep medications are tools—not the foundation of good sleep. The episode frames sleep problems around four underlying mechanisms: sleep pressure, circadian timing, hyperarousal, and sleep architecture. From there, Attia compares major prescription sleep drug classes, explains why some are better matched to certain sleep complaints than others, and highlights the strongest and weakest evidence for commonly used supplements.

Core Framework for Understanding Sleep Problems

The 4 drivers of sleep

Most sleep issues can be traced to one or more of the following:

• Sleep pressure: the longer you stay awake, the stronger the drive to sleep
• Circadian timing: whether your internal clock is aligned with the light-dark cycle
• Hyperarousal: the brain is “stuck on,” often due to stress, anxiety, or learned wakefulness
• Sleep architecture: whether the sleep you get is actually restorative and properly structured

Why sleep is difficult in modern life

Attia argues that humans have engineered environments that disrupt all four systems:

• Too little daylight exposure during the day
• Too much artificial light at night
• Irregular sleep/wake schedules
• Heavy caffeine use, alcohol use, travel, and shift work
• Chronic stress and mental overload

First-Line Foundations Before Medication

Sleep hygiene and behavioral alignment

He stresses that good sleep usually starts with behavior, not pills:

• Keep consistent wake and bedtimes
• Get morning sunlight soon after waking
• Reduce light exposure and stimulation before bed
• Keep the bedroom cool and dark
• Exercise earlier in the day when possible
• Avoid late caffeine, excessive napping, and sleeping in

Rule out common medical causes

Before treating insomnia with meds, he recommends checking for:

• Restless leg syndrome
• Obstructive sleep apnea
• Mood disorders such as anxiety, depression, and bipolar disorder

CBT-I is first-line for insomnia

Attia reinforces that cognitive behavioral therapy for insomnia (CBT-I) is the best first-line treatment for chronic insomnia because it targets hyperarousal and retrains the brain’s association between bed and wakefulness.

Why Not All “Insomnia” Is the Same

Different sleep complaints need different treatments

He breaks sleep problems into practical buckets:

• Trouble falling asleep → often hyperarousal
• Trouble staying asleep → often more common than sleep-onset issues
• Early morning awakenings → often circadian misalignment
• Fragmented/non-restorative sleep → often inadequate slow-wave sleep

Sedation is not the same as natural sleep

A major theme of the episode is that many sleep medications create unconsciousness, not true physiologic sleep.

• True sleep includes N1, N2, N3/slow-wave sleep, and REM
• Slow-wave sleep supports physical restoration, memory consolidation, and brain waste clearance
• REM sleep supports emotional and procedural memory
• Many sedatives flatten or disrupt this architecture

Major Prescription Sleep Medication Classes

1) Benzodiazepines

Examples: temazepam, lorazepam, alprazolam, diazepam, clonazepam

How they work

• Enhance GABA-A signaling
• Reduce hyperarousal and sedation follows from dampening brain activity

Benefits

• Help with sleep onset
• Can reduce anxiety quickly
• May increase total sleep time

Major downsides

• Reduce slow-wave sleep and suppress REM sleep
• High risk of tolerance, dependence, and withdrawal
• Can cause rebound insomnia
• Increase falls, especially in older adults
• Dangerous with alcohol, opioids, or sleep apnea
• Can impair memory, balance, cognition, and psychomotor speed
• Can cause complex sleep behaviors and anterograde amnesia

Bottom line

• Effective short-term, but poor choice for chronic use due to architecture disruption and dependence risk

2) Z-drugs

Examples: zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata)

How they work

• Also act on GABA-A receptors, but are more “targeted” than benzos

Differences by agent

• Lunesta: longer half-life, can help with onset and maintenance
• Ambien: better for sleep onset
• Sonata: very short half-life, sometimes used for middle-of-the-night awakening

Benefits

• Reduce sleep latency
• Modestly increase total sleep time

Major downsides

• Still can disrupt sleep architecture
• Cause anterograde amnesia
• Carry risks of dependence
• Impair coordination, balance, attention, and memory
• Can trigger dangerous complex sleep behaviors:
  • sleepwalking
  • sleep eating
  • shopping
  • driving
  • sex while unconscious or dissociated

Bottom line

• Designed as “cleaner” benzos, but many of the same problems remain

3) Dual Orexin Receptor Antagonists (DORAs)

Examples: suvorexant (Belsomra), lemborexant (Dayvigo), daridorexant (Quviviq)

How they work

• Instead of forcing sedation, they reduce wakefulness signaling by blocking the orexin system

Why Attia likes them

• More physiologic: they allow sleep rather than bluntly forcing unconsciousness
• Generally preserve sleep architecture
• Little or no suppression of slow-wave sleep, with possible REM preservation or improvement
• Strong evidence for sleep efficiency and total sleep time
• Tolerability appears better than many older hypnotics

Important caveats

• Can cause next-day sedation, especially at higher doses or in older adults
• Half-lives vary:
  • Quviviq: ~6–10 hours
  • Belsomra: ~12 hours
  • Dayvigo: ~17–19 hours
• May cause narcolepsy-like symptoms:
  • sleep paralysis
  • hypnagogic hallucinations
  • daytime sleepiness
  • rare sleep attacks or cataplexy-like episodes
• Not for patients with narcolepsy

Emerging research Attia spends significant time on the hypothesis that DORAs may support glymphatic clearance during sleep and could have implications for Alzheimer’s disease risk.

• Animal studies suggest reduced beta-amyloid and tau accumulation
• A small human study showed a signal for reduced CSF amyloid beta with Belsomra
• However, he emphasizes that this is early, hypothesis-generating evidence, not a reason to use DORAs for dementia prevention outside research settings

Bottom line

• Probably the most promising current class for many patients because they preserve sleep more naturally and may have broader future implications

4) Melatonin and Melatonin Receptor Agonists

Examples:

• Melatonin supplement
• Ramelteon and related prescription agonists

How they work

• They are circadian timing signals, not sedatives
• Act on the brain’s circadian center, the suprachiasmatic nucleus (SCN)

Best use cases

• Jet lag
• Shift work
• Daylight savings adjustment
• Delayed sleep phase / “night owl” patterns

Important details

• Melatonin is not a sleeping pill
• Best taken 1–3 hours before bed
• A dose around 4 mg appears optimal in meta-analysis; more is not necessarily better
• Too much melatonin can worsen circadian alignment or cause hangover effects

Supplement concerns

• Actual melatonin content in supplements can vary wildly from the label
• Gummies may be especially unreliable
• Bioavailability is highly variable

Prescription agonists

• More reliable dosing and manufacturing than supplements
• Low abuse/dependence risk
• Generally well tolerated

Bottom line

• Best when the real problem is timing, not general insomnia

5) Trazodone

Originally an antidepressant, now commonly used off-label for sleep

Why it’s popular

• Inexpensive
• Not controlled
• Generally safe
• Often used at low doses for insomnia

How it works

• Blocks 5-HT2, histamine H1, and alpha-1 adrenergic receptors

Benefits

• Increases total sleep time
• Unusually, it can increase slow-wave sleep rather than suppress it

Risks

• Morning grogginess
• Dizziness
• Orthostatic hypotension and falls
• Rare but serious: priapism, arrhythmias

Bottom line

• One of Attia’s preferred options for longer-term use if tolerated, especially compared with classic sedatives

6) First-Generation Antihistamines

Examples: diphenhydramine (Benadryl), doxylamine (Unisom), PM cold/pain products

Why they’re used

• Easy to obtain
• Cause drowsiness via H1 blockade

Problems

• Tolerance develops quickly
• Strong anticholinergic side effects:
  • dry mouth
  • constipation
  • urinary retention
  • blurred vision
  • cognitive slowing
• May worsen narrow-angle glaucoma
• Long-term anticholinergic burden may be associated with dementia risk

Bottom line

• Only appropriate for very short-term use, if at all

Evidence on Common Sleep Supplements

General warning about supplements

Attia strongly cautions that supplements are not regulated like medications:

• Labels may not match actual contents
• Potency can vary significantly
• Contamination or adulteration can occur

He recommends looking for:

• USP Verified
• NSF Certified for Sport
• Independent testing via ConsumerLab or Labdoor

Supplements discussed

Glycine

• Cheap and safe
• Some modest evidence for sleep benefit
• Effect size is small, but signal is favorable

Magnesium

• Popular, but evidence for sleep is underwhelming
• May help most if someone is actually deficient
• Attia does not view it as a primary sleep strategy

Ashwagandha

• Some evidence of modest sleep benefit, especially in insomnia
• May reduce cortisol
• Main caution: quality variability and possible adverse effects, including:
  • GI upset
  • thyroid issues
  • liver injury

Phosphatidylserine

• Sometimes used to lower stress-related cortisol
• Attia says he often uses it in jet lag protocols
• He commonly pairs it with melatonin for forced circadian shifts

Main Clinical Takeaways

Match the treatment to the mechanism

Attia’s central message is that sleep problems should not all be treated the same way.

• Hyperarousal → CBT-I, anxiety reduction, sometimes short-term meds
• Circadian misalignment → melatonin, melatonin agonists, light timing
• Sleep onset insomnia → short-acting agents may help
• Sleep maintenance insomnia → longer-acting agents may be more appropriate
• Non-restorative or fragmented sleep → think architecture, apnea, other medical causes

Medications are bridges, not the foundation

Sleep meds can help, especially in:

• acute crises
• chronic pain
• travel/shift work
• entrenched anxiety
• temporary sleep disruption

But they should be:

• precisely matched
• used at the lowest effective dose
• used for the shortest practical duration
• paired with a plan to address the underlying cause

The big warning

The most common mistake is treating all insomnia as one problem and reaching for a drug randomly. In sleep medicine, that often leads to:

• dependence
• tolerance
• worse sleep architecture
• worse cognition
• more medication for less benefit

Final Takeaway

Sleep is not just “being knocked out.” It is a highly organized biological process shaped by sleep pressure, circadian timing, arousal state, and sleep architecture. Attia’s practical message is that the best approach is to align behavior with biology first, rule out medical causes, use CBT-I when appropriate, and reserve medications as carefully chosen tools rather than default solutions.